SUBJECTS
|
BROWSE
|
CAREER CENTER
|
POPULAR
|
JOIN
|
LOGIN
Business Skills
|
Soft Skills
|
Basic Literacy
|
Certifications
About
|
Help
|
Privacy
|
Terms
|
Email
Search
Test your basic knowledge |
Introduction To Biomedical Engineering
Start Test
Study First
Subject
:
engineering
Instructions:
Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can
study here
.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.
This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.
1. Flexible - light - can be translucent or not transparent - can be degradable or stable - easy to work with - inexpensive
polymers (5)
mean arterial pressure
medial
oncogene
2. <25% results in heart failure
stroke volume
coronary arteries
human subject research procedure 3
if the stroke volume is less than this
3. Closer to the head
rough ER
larger molecules require
superior
sacromere
4. __________ of PDP are reported to the FDA
two ways larger molecules pass through cell membrane
routes for registerting a new medical device in the US (4)
therapeutic experiment example 2
milestones
5. Initiates human research study protocol - It's a document that outlines in detail scientific purpose of study - methods used - possible risks to patient - etc
strain - e
flexion
m - cell cycle
investigator
6. Protein called tubulin
coronary arteries
what microtubules contain
PMA
stroke volume
7. Genotyping to determine risk factors for disease
non - therapeutic experiment example 2
frontal plane
residual volume =
midsagittal plane
8. Deliver oxygenated blood to cardiac tissue - derive oxygenated blood via Sinuses of Valsalva - fill with blood on diastole - heart muscle relaxes during diastole
Hooke's law - s
passive transport
cell cycle (4)
coronary arteries
9. Contains ribosomes - protein synthesis
why 510(k)'s standard for clearance is lower
rough ER
g1 - cell cycle
proximal
10. Consent should be attained from the subject by a person NOT engaged in the research and completely independent
conflict of interest - informed consent
a completed PDP
abduction
pulse pressure
11. Temporary functions; do not require second surgery for removal
device classification has
central nervous system
biodegradable materials have
therapeutic experiment
12. Institutional review board - consider the ethical aspects - to evaluate - approve - and monitor proposals to perform human research
inferior
IRB
PDP
active transport
13. Intracellular
PDP
cell cycle (4)
what microtubules contain
lower ion concentration of Cl
14. Divides the body in posterior and anterior halves
plasma membrane acts
investigator
frontal plane
class II examples
15. 2/3 diastolic pressure + 1/3 systolic pressure
mean arterial pressure
why IDE's are common
pronation
PMA
16. The remainder of the pleura left in the cavity
parietal pleura
biodegradable materials have
class I
non - therapeutic experiment
17. Trial of artificial kidneys
510(k) must prove this
if the stroke volume is less than this
therapeutic experiment example 2
anterior view
18. Study of the impact of hepatitis infection
pulse pressure
inferior
non - therapeutic experiment example 1
conflict of interest - informed consent
19. Neared to the end of the limbs
tumor suppressor gene
why IDE's are common
frontal plane
distal
20. Stiff and brittle - good insulators of heat and electricity - very high melting point - hard - wear resistant
plasma membrane acts
ceramics are (5)
central nervous system
cell cycle (4)
21. Investigational device exemption - allows companies and researches to use their new devices/technology for investigational use only - used to Generate data before PMA's
IDE
IRB review areas (4)
extension
what microtubules contain
22. PMA - 510(k) notification - IDE - PDP
therapeutic experiment example 2
passive transport
routes for registerting a new medical device in the US (4)
investigator
23. Protein channels to pass through cell membrane
therapeutic experiment example 2
metals are (6)
age - informed consent
larger molecules require
24. F/ A0
medial
ceramics are (5)
stress - s
PMA
25. Clinical evaluation of new devices are critical to prove safety
26. Injury with tissue - bleeding and clotting (coagulation cascade) - acute inflammation - pink granulation tissues replaces matrix - tissue is remodeled back to original state
competence - informed consent
healing response
milestones
g2 - cell cycle
27. Divides the body into superior and inferior halves
transverse plane
abduction
supination
classes of biomaterials (4)
28. Conflict of interest - competence - and age
why 510(k)'s standard for clearance is lower
tumor suppressor gene
attaining informed consent (3)
metals are (6)
29. V diastole - V systole
Lower ion concentration of K
FDA
stroke volume
the protocol for human subject research
30. G1 - s - g2 - m
cell cycle (4)
inferior
cardiac output
why 510(k)'s standard for clearance is lower
31. Water adsorption - reduction of length - reduction of strength - weight loss
proximal
rough ER
FDA
degradation steps
32. Clinical trial of new chemotherapy drug
therapeutic experiment example 1
visceral pleura
flexion
m - cell cycle
33. Product development protocol - alternatives to IDE and PMA processes for new devices
lateral
PDP
human subject research procedure 2
classes of biomaterials (4)
34. Strong and ductile - good conductor of heat and electricity - high melting point - high density - shiny and reflective - numerous
human subject research procedure 2
if the stroke volume is less than this
metals are (6)
why IDE's are common
35. Growth phase 1
mean arterial pressure
plasma membrane acts
two ways larger molecules pass through cell membrane
g1 - cell cycle
36. Programmed cell death
active transport
What a PDP - sponsor and FDA agree on
apoptosis
therapeutic experiment
37. 'substantial equivalence' to another approved and safe device to technology currently on the market
IDE
flexion
510(k) must prove this
proximal
38. Mitosis
peripheral nervous system
m - cell cycle
class III examples
device classification has
39. Serious level of risk; implants or necessary to sustain life; require PMA
class III
a 'biodegradable' product has the ability to break down
plasma membrane acts
class III examples
40. Closer to the feet
adduction
synovial joints have
inferior
passive transport
41. Total lung capacity - vital capacity
pulse pressure
sagittal plane
class II
residual volume =
42. Total lung capacity - inspiratory capacity
functional residual capacity =
510(k)'s standard for clearance
distal
mitochondria
43. Safely and reliably - 'relatively' quickly - into raw materials of nature
44. Nearer to the trunk of the body
distal
anterior view
proximal
lateral
45. Translations - appropriate language - obtained in writing - and informed that they may abstain or withdraw from the study at any time
lower ion concentration of Cl
cell cycle (4)
mitochondria
informed consent documents (4)
46. Motion where the body part is extended from the medial line (side- to- side)
visceral pleura
cardiac output
abduction
the protocol for human subject research
47. Fluid- filled cavities and are most complex and varied types of joints
synovial joints have
informed consent
competence - informed consent
visceral pleura
48. Consists of all nervous tissue that is enclosed by bone (brain and spinal cord)
non - therapeutic experiment example 1
flexion
central nervous system
small molecules
49. lower ion concentration of Na
s - cell cycle
Intracellular
510(k) must prove this
how IDE's can be granted
50. Metals - ceramics - polymers - biologics
active transport
FDA
classes of biomaterials (4)
if the stroke volume is less than this